Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin plus Exemestane in Adjuvant Breast Cancer
NCT01431053Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jul 2011
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in breast cancer, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
aspirin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01431053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431053.